Crop Life Science MD, chairman, board of directors and AGM
NSE: CLSLFertilizers & Agrochemicals
Share price at the NSE close on 22 Oct 2026. Previous close ₹70.95.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹128 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 26 May 2026
- 19.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 26 May 2026
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 26 May 2026
- 9.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.61
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 14,000100.0% delivered
Crop Life Science board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Shah & Shah, Chartered AccountantsPeer-review certificate valid to Aug 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Crop Life Science AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Crop Life Science share news and announcements
Annual general meeting, 23 Sep 2026
828 shareholders on the register on 16 Sep 2026; present: 15 promoters and 8 others; votes counted by Mr. Ranjit Kumar Singh / M/S Ranjit & Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Standalone Financial Statements and Consolidated Financial Statements of the Company for the Financial Year ended on 31st March, 2026 together with report of the Board of Directors & Auditors thereonMoreLess
Ordinary99.98% for0.02% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 77.34% · promoters 100.00% · institutions 0.00% · other public 30.89%
- To appoint a director in place of Mr. Ashvinkumar Ravji Lunagaria (DIN 02731913), who retires by rotation and being eligible, offers himself for re-appointmentOrdinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 57.53% · promoters 100.00% · institutions 0.00% · other public 15.07%
- Ratification of remuneration to Cost Auditors for the financial year 2026-27Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 77.34% · promoters 100.00% · institutions 0.00% · other public 30.89%
- Appointment Of Mr. Alpeshbhai Gordhanbhai Vaghasiya (DIN: 11746290) As Non-Executive Independent Director of The CompanySpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.12%
Turnout: all 77.34% · promoters 100.00% · institutions 0.00% · other public 30.89%
- Appointment of Mr. Pareshbhai Bhagvanbhai Parsana (Din: 11758906) As A Non-Executive Independent Director of The CompanySpecial99.98% for0.02% against
Against: promoters 0.00% · other public 0.12%
Turnout: all 77.34% · promoters 100.00% · other public 30.89%
- Approval of Material Related Party Transaction with Hetban Spechem LimitedOrdinary99.84% for0.16% against
Against: promoters 0.00% · institutions 0.00% · other public 0.16%
Turnout: all 7.33% · promoters 0.00% · institutions 0.00% · other public 22.35%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 24 Jun 2026, 1 resolution
1,061 shareholders on the register on 15 May 2026; votes counted by Ranjit Kumar Singh / Ranjit & Associates.The company's voting result (opens in a new tab)
- REGULARIZATION OF APPOINTMENT OF MS SHEETALBEN RACHIT SHAH AS A NON EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANYSpecial99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 74.00% · promoters 100.00% · institutions 0.00% · other public 13.31%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Jun 2026.
- Tax disputeGovernment of India, Service Tax DepartmentSince 12 Apr 2022Proceedings ongoingAt the filing before: Appeal Filed
- Tax disputeCESTAT, AhmedabadSince 16 Jun 2026Proceedings ongoingAt the filing before: Appeal Filed
- Tax disputeGovernment of Maharashtra, Goods and Service Tax DepartmentSince 5 Feb 2025Proceedings ongoing
- Tax disputeOffice of The Commissioner (Appeals), Central Goods and Service Tax, VadodaraSince 25 Jun 2026Proceedings ongoing
- Tax disputeGovernment of India, Income Tax DepartmentSince 2 Jan 2026Proceedings ongoing
- Tax disputeGovernment of India, Income Tax DepartmentSince 10 Mar 2026Proceedings ongoing
- Tax disputeUttar Pradesh VAT DepartmentProceedings ongoing
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2025. The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesAug 2023 | 26.73 | Repayment Unsecured Loan | 0.70 | 0.70 | No |
| Public IssuesAug 2023 | 26.73 | Long-Term Working Capital Requirement | 19.00 | 19.00 | No |
| Public IssuesAug 2023 | 26.73 | General Corporate Purpose | 6.50 | 6.50 | No |
| Public IssuesAug 2023 | 26.73 | Issue related expenses | 0.53 | 0.53 | No |